Jenburkt Pharma Hits 52-Week High, Outperforms Sector with Strong 1-Year Performance
Jenburkt Pharmaceuticals Ltd., a microcap pharmaceutical company, has hit a 52-week high on January 15, 2024, with a current price of Rs. 858.8. The stock has outperformed the sector by 5.08% and has been on a consecutive gain for the past two days, with a 16.4% increase. It is currently trading higher than its moving averages, indicating a positive trend. With a strong 1-year performance, the company has caught the attention of investors.
Jenburkt Pharmaceuticals Ltd., a microcap pharmaceutical company, has recently hit a 52-week high on January 15, 2024. The stock has been performing well in the market, with a current price of Rs. 858.8. MarketsMOJO has given a 'Hold' call for the stock.
In today's trading session, Jenburkt Pharma has outperformed the sector by 5.08%. The stock has been on a consecutive gain for the past two days, with a 16.4% increase in returns during this period. It opened with a gain of 2.19% and touched an intraday high of Rs. 858.8, which is a 6.37% increase.
Jenburkt Pharma is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in the stock's performance.
In the past year, Jenburkt Pharmaceuticals has shown a strong performance with a 29.42% increase, outperforming the Sensex's performance of 21.60%. This showcases the company's growth and potential in the pharmaceutical industry.
Jenburkt Pharmaceuticals is a microcap company, but its recent performance in the market has caught the attention of investors. With a 'Hold' call from MarketsMOJO and a strong 1-year performance, the company is definitely one to watch out for in the pharma industry.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
